Pictet Asset Management (UK)’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,100
Closed -$274K 1843
2021
Q1
$274K Sell
5,100
-200
-4% -$11.5K ﹤0.01% 1491
2020
Q4
$259K Buy
+5,300
New +$246K ﹤0.01% 1478
2020
Q3
Sell
-1,106,123
Closed -$28.6M 1577
2020
Q2
$28.6M Buy
1,106,123
+52,756
+5% +$1.31M 0.05% 335
2020
Q1
$25.6M Sell
1,053,367
-66,060
-6% -$1.66M 0.05% 323
2019
Q4
$31.3M Buy
1,119,427
+221,871
+25% +$5.74M 0.06% 356
2019
Q3
$21.5M Buy
+897,556
New +$23.9M 0.05% 376

Other funds holding VCYT

Pictet Asset Management (UK)'s VCYT Position: Q2 2021 in Review

Pictet Asset Management (UK) sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 5,100 shares — an estimated $274K sold.

Pictet Asset Management (UK) first reported a position in VCYT in Q3 2019 and held it in 6 quarters. The position peaked at $31.3M in Q4 2019. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Pictet Asset Management (UK) reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 5,100 Veracyte shares in Q2 2021, an estimated $274K.
  • Pictet Asset Management (UK) first reported a position in Veracyte in Q3 2019 and held it in 6 quarters.
  • Pictet Asset Management (UK)'s Veracyte position peaked at $31.3M in Q4 2019.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.